Exosomes: The link between GPCR activation and metastatic potential?

Frontiers in Genetics

Volumn 7, Issue APR, 2016, Pages

  Isola, Allison L ^a,b   Chen, Suzie ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Cancer; Exosome; GPCR; MGluR; Pre metastatic niche

Indexed keywords

CD63 ANTIGEN; CD81 ANTIGEN; CD82 ANTIGEN; CD9 ANTIGEN; ESCRT PROTEIN; FRIZZLED PROTEIN; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; GLYPICAN 1; GUANOSINE TRIPHOSPHATE; INOSITOL TRISPHOSPHATE; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 5; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN KINASE B; PROTEIN KINASE C; RHODOPSIN; SECRETIN; TENASCIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNINDEXED DRUG;

ADENYLATE CYCLASE ASSAY; ADHESION; ANGIOGENESIS; BONE MARROW DERIVED DENDRITIC CELL; CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CIRCULATING TUMOR CELL; ENDOCRINE DISEASE; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; METASTASIS POTENTIAL; MOLECULARLY TARGETED THERAPY; MULTIVESICULAR BODY; NEPHROGENIC DIABETES INSIPIDUS; ONCOGENE; PHYLOGENY; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE;

EID: 84964798275     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2016.00056     Document Type: Review

References (147)

1. Admyre, C., Johansson, S. M., Qazi, K. R., Filen, J. J., Lahesmaa, R., Norman, M., et al. (2007). Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179, 1969-1978. doi: 10.4049/jimmunol.179.3.1969.
2. Aliotta, J. M., Pereira, M., Johnson, K. W., de Paz, N., Dooner, M. S., Puente, N., et al. (2010). Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp. Hematol. 38, 233-245. doi: 10.1016/j.exphem.2010.01.002.
3. Andre, F., Schartz, N. E., Chaput, N., Flament, C., Raposo, G., Amigorena, S., et al. (2002). Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 20(Suppl. 4), A28-A31. doi: 10.1016/s0264-410x(02)00384-5.
4. Arcella, A., Carpinelli, G., Battaglia, G., D'Onofrio, M., Santoro, F., Ngomba, R. T., et al. (2005). Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro Oncol. 7, 236-245. doi: 10.1215/S1152851704000961.
5. Attwood, T. K., and Findlay, J. B. (1994). Fingerprinting G-protein-coupled receptors. Protein Eng. 7, 195-203. doi: 10.1093/protein/7.2.195.
6. Baietti, M. F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., et al. (2012). Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14, 677-685. doi: 10.1038/ncb2502.
7. Baj-Krzyworzeka, M., Szatanek, R., Weglarczyk, K., Baran, J., Urbanowicz, B., Branski, P., et al. (2006). Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 55, 808-818. doi: 10.1007/s00262-005-0075-9.
8. Balaj, L., Lessard, R., Dai, L., Cho, Y. J., Pomeroy, S. L., Breakefield, X. O., et al. (2011). Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2:180. doi: 10.1038/ncomms1180.
9. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744. doi: 10.1038/35036374.
10. Bjarnadottir, T. K., Fredriksson, R., and Schioth, H. B. (2005). The gene repertoire and the common evolutionary history of glutamate, pheromone (V2R), taste(1) and other related G protein-coupled receptors. Gene 362, 70-84. doi: 10.1016/j.gene.2005.07.029.
11. Brocke, K. S., Staufner, C., Luksch, H., Geiger, K. D., Stepulak, A., Marzahn, J., et al. (2010). Glutamate receptors in pediatric tumors of the central nervous system. Cancer Biol. Ther. 9, 455-468. doi: 10.4161/cbt.9.6.10898.
12. Bunemann, M., Frank, M., and Lohse, M. J. (2003). Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc. Natl. Acad. Sci. U.S.A. 100, 16077-16082. doi: 10.1073/pnas.2536719100.
13. Burger, J. A., Spoo, A., Dwenger, A., Burger, M., and Behringer, D. (2003). CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis). Br. J. Haematol. 122, 579-589. doi: 10.1046/j.1365-2141.2003.04466.x.
14. Caby, M. P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., and Bonnerot, C. (2005). Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17, 879-887. doi: 10.1093/intimm/dxh267.
15. Cancer Genome Atlas Research, N. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068. doi: 10.1038/nature07385.
16. Chang, H. J., Yoo, B. C., Lim, S. B., Jeong, S. Y., Kim, W. H., and Park, J. G. (2005). Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin. Cancer Res. 11, 3288-3295. doi: 10.1158/1078-0432.CCR-04-1912.
17. Choi, K. Y., Chang, K., Pickel, J. M., Badger, J. D. II., and Roche, K. W. (2011). Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 108, 15219-15224. doi: 10.1073/pnas.1107304108.
18. Chow, A., Zhou, W., Liu, L., Fong, M. Y., Champer, J., Van Haute, D., et al. (2014). Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-kappaB. Sci. Rep. 4:5750. doi: 10.1038/srep05750.
19. Christianson, H. C., Svensson, K. J., van Kuppevelt, T. H., Li, J. P., and Belting, M. (2013). Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc. Natl. Acad. Sci. U.S.A. 110, 17380-17385. doi: 10.1073/pnas.1304266110.
20. Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., et al. (2015). Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17, 816-826. doi: 10.1038/ncb3169.
21. da Silveira, J. C., Veeramachaneni, D. N., Winger, Q. A., Carnevale, E. M., and Bouma, G. J. (2012). Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle. Biol. Reprod. 86:71. doi: 10.1095/biolreprod.111.093252.
22. D'Onofrio, M., Arcella, A., Bruno, V., Ngomba, R. T., Battaglia, G., Lombari, V., et al. (2003). Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells. J. Neurochem. 84, 1288-1295. doi: 10.1046/j.1471-4159.2003.01633.x.
23. Durinck, S., Ho, C., Wang, N. J., Liao, W., Jakkula, L. R., Collisson, E. A., et al. (2011). Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 1, 137-143. doi: 10.1158/2159-8290.CD-11-0028.
24. Enriquez, V. A., Cleys, E. R., Da Silveira, J. C., Spillman, M. A., Winger, Q. A., and Bouma, G. J. (2015). High LIN28A expressing ovarian cancer cells secrete exosomes that induce invasion and migration in HEK293 Cells. Biomed Res. Int. 2015:701390. doi: 10.1155/2015/701390.
25. Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., et al. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44. doi: 10.1016/j.ccr.2008.11.012.
26. Escola, J. M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O., and Geuze, H. J. (1998). Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273, 20121-20127. doi: 10.1074/jbc.273.32.20121.
27. Escrevente, C., Keller, S., Altevogt, P., and Costa, J. (2011). Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer 11:108. doi: 10.1186/1471-2407-11-108.
28. Esseltine, J. L., Willard, M. D., Wulur, I. H., Lajiness, M. E., Barber, T. D., and Ferguson, S. S. (2013). Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling. Mol. Pharmacol. 83, 770-780. doi: 10.1124/mol.112.081695.
29. Farsad, K., Ringstad, N., Takei, K., Floyd, S. R., Rose, K., and De Camilli, P. (2001). Generation of high curvature membranes mediated by direct endophilin bilayer interactions. J. Cell Biol. 155, 193-200. doi: 10.1083/jcb.200107075.
30. Fidler, I. J. (2003). The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat. Rev. Cancer 3, 453-458. doi: 10.1038/nrc1098.
31. Fidler, I. J., and Hart, I. R. (1982). Biological diversity in metastatic neoplasms: origins and implications. Science 217, 998-1003. doi: 10.1126/science.7112116.
32. Ford, M. G., Mills, I. G., Peter, B. J., Vallis, Y., Praefcke, G. J., Evans, P. R., et al. (2002). Curvature of clathrin-coated pits driven by epsin. Nature 419, 361-366. doi: 10.1038/nature01020.
33. Frati, C., Marchese, C., Fisichella, G., Copani, A., Nasca, M. R., Storto, M., et al. (2000). Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. J. Cell. Physiol. 183, 364-372. doi: 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.0.CO;2-X.
34. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., and Schioth, H. B. (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272. doi: 10.1124/mol.63.6.1256.
35. Fujita, Y., Yoshioka, Y., Ito, S., Araya, J., Kuwano, K., and Ochiya, T. (2014). Intercellular communication by extracellular vesicles and their microRNAs in asthma. Clin. Ther. 36, 873-881. doi: 10.1016/j.clinthera.2014.05.006.
36. Futter, C. E., Pearse, A., Hewlett, L. J., and Hopkins, C. R. (1996). Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. J. Cell Biol. 132, 1011-1023. doi: 10.1083/jcb.132.6.1011.
37. Gao, D., Joshi, N., Choi, H., Ryu, S., Hahn, M., Catena, R., et al. (2012). Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 72, 1384-1394. doi: 10.1158/0008-5472.CAN-11-2905.
38. Gatti, J. L., Metayer, S., Belghazi, M., Dacheux, F., and Dacheux, J. L. (2005). Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles. Biol. Reprod. 72, 1452-1465. doi: 10.1095/biolreprod.104.036426.
39. Gonzalez-Begne, M., Lu, B., Han, X., Hagen, F. K., Hand, A. R., Melvin, J. E., et al. (2009). Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J. Proteome Res. 8, 1304-1314. doi: 10.1021/pr800658c.
40. Guescini, M., Leo, G., Genedani, S., Carone, C., Pederzoli, F., Ciruela, F., et al. (2012). Microvesicle and tunneling nanotube mediated intercellular transfer of g-protein coupled receptors in cell cultures. Exp. Cell Res. 318, 603-613. doi: 10.1016/j.yexcr.2012.01.005.
41. Hamm, H. E. (1998). The many faces of G protein signaling. J. Biol. Chem. 273, 669-672. doi: 10.1074/jbc.273.2.669.
42. Hata, J. A., and Koch, W. J. (2003). Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease. Mol. Interv. 3, 264-272. doi: 10.1124/mi.3.5.264.
43. Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H. J., and Sixma, J. J. (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791-3799.
44. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., et al. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637. doi: 10.1016/S0092-8674(02)00754-7.
45. Henne, W. M., Stenmark, H., and Emr, S. D. (2013). Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perspect Biol 5:a016766. doi: 10.1101/cshperspect.a016766.
46. Hermans, E., and Challiss, R. A. (2001). Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem. J. 359, 465-484. doi: 10.1042/bj3590465.
47. Hiratsuka, S., Watanabe, A., Aburatani, H., and Maru, Y. (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375. doi: 10.1038/ncb1507.
48. Hood, J. L., Pan, H., Lanza, G. M., Wickline, S. A., Consortium for Translational Research in Advanced I. and Nanomedicine (2009). Paracrine induction of endothelium by tumor exosomes. Lab. Invest. 89, 1317-1328. doi: 10.1038/labinvest.2009.94.
49. Hood, J. L., San, R. S., and Wickline, S. A. (2011). Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792-3801. doi: 10.1158/0008-5472.CAN-10-4455.
50. Hsu, C., Morohashi, Y., Yoshimura, S., Manrique-Hoyos, N., Jung, S., Lauterbach, M. A., et al. (2010). Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 189, 223-232. doi: 10.1083/jcb.200911018.
51. Huang, Y., Song, N., Ding, Y., Yuan, S., Li, X., Cai, H., et al. (2009). Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res. 69, 7529-7537. doi: 10.1158/0008-5472.CAN-08-4382.
52. Huber, V., Filipazzi, P., Iero, M., Fais, S., and Rivoltini, L. (2008). More insights into the immunosuppressive potential of tumor exosomes. J. Transl. Med. 6, 63. doi: 10.1186/1479-5876-6-63.
53. Huhtala, P., Humphries, M. J., McCarthy, J. B., Tremble, P. M., Werb, Z., and Damsky, C. H. (1995). Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol. 129, 867-879. doi: 10.1083/jcb.129.3.867.
54. Hurley, J. H., and Hanson, P. I. (2010). Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat. Rev. Mol. Cell Biol. 11, 556-566. doi: 10.1038/nrm2937.
55. Hurley, J. H., and Odorizzi, G. (2012). Get on the exosome bus with ALIX. Nat. Cell Biol. 14, 654-655. doi: 10.1038/ncb2530.
56. Hyenne, V., Apaydin, A., Rodriguez, D., Spiegelhalter, C., Hoff-Yoessle, S., Diem, M., et al. (2015). RAL-1 controls multivesicular body biogenesis and exosome secretion. J. Cell Biol. 211, 27-37. doi: 10.1083/jcb.201504136.
57. Hyun, K. A., Kim, J., Gwak, H., and Jung, H. I. (2015). Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics. Analyst. 141, 382-392. doi: 10.1039/C5AN01762A.
58. Iacovelli, L., Arcella, A., Battaglia, G., Pazzaglia, S., Aronica, E., Spinsanti, P., et al. (2006). Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J. Neurosci. 26, 8388-8397. doi: 10.1523/JNEUROSCI.2285-06.2006.
59. Iero, M., Valenti, R., Huber, V., Filipazzi, P., Parmiani, G., Fais, S., et al. (2008). Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 15, 80-88. doi: 10.1038/sj.cdd.4402237.
60. Julius, D., Livelli, T. J., Jessell, T. M., and Axel, R. (1989). Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244, 1057-1062. doi: 10.1126/science.2727693.
61. Kahlert, C., Melo, S. A., Protopopov, A., Tang, J., Seth, S., Koch, M., et al. (2014). Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J. Biol. Chem. 289, 3869-3875. doi: 10.1074/jbc. C113.532267.
62. Kalariti, N., Lembessis, P., Papageorgiou, E., Pissimissis, N., and Koutsilieris, M. (2007). Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG-63 osteoblast-like osteosarcoma cells. J. Musculoskelet. Neuronal Interact. 7, 113-118.
63. Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., et al. (2010). Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869-873. doi: 10.1038/nature09208.
64. Kaplan, R. N., Rafii, S., and Lyden, D. (2006). Preparing the "soil": the premetastatic niche. Cancer Res. 66, 11089-11093. doi: 10.1158/0008-5472.CAN-06-2407.
65. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827. doi: 10.1038/nature04186.
66. Katzmann, D. J., Babst, M., and Emr, S. D. (2001). Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106, 145-155. doi: 10.1016/S0092-8674(01)00434-2.
67. Keller, S., Rupp, C., Stoeck, A., Runz, S., Fogel, M., Lugert, S., et al. (2007). CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 72, 1095-1102. doi: 10.1038/sj.ki.5002486.
68. Kii, I., Nishiyama, T., Li, M., Matsumoto, K., Saito, M., Amizuka, N., et al. (2010). Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J. Biol. Chem. 285, 2028-2039. doi: 10.1074/jbc. M109.051961.
69. Kolakowski, L. F. Jr. (1994). GCRDb: a G-protein-coupled receptor database. Recept. Channels 2, 1-7.
70. Lagerstrom, M. C., and Schioth, H. B. (2008). Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339-357. doi: 10.1038/nrd2518.
71. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. doi: 10.1038/35057062.
72. Lappano, R., and Maggiolini, M. (2011). G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov. 10, 47-60. doi: 10.1038/nrd3320.
73. Lee, H. J., Wall, B., and Chen, S. (2008). G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res. 21, 415-428. doi: 10.1111/j.1755-148X.2008.00478.x.
74. Lespagnol, A., Duflaut, D., Beekman, C., Blanc, L., Fiucci, G., Marine, J. C., et al. (2008). Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 15, 1723-1733. doi: 10.1038/cdd.2008.104.
75. Liotta, L. A., and Stetler-Stevenson, W. G. (1991). Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51, 5054s-5059s.
76. Lipowsky, R. (2013). Spontaneous tubulation of membranes and vesicles reveals membrane tension generated by spontaneous curvature. Faraday Discuss. 161, 305-331; discussion 419-359. doi: 10.1039/C2FD20105D.
77. Locke, C. J., Congrove, N. R., Dismuke, W. M., Bowen, T. J., Stamer, W. D., and McKay, B. S. (2014). Controlled exosome release from the retinal pigment epithelium in situ. Exp. Eye Res. 129, 1-4. doi: 10.1016/j.exer.2014.10.010.
78. Logozzi, M., De Milito, A., Lugini, L., Borghi, M., Calabro, L., Spada, M., et al. (2009). High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4:e5219. doi: 10.1371/journal.pone.0005219.
79. Marin, Y. E., and Chen, S. (2004). Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. J. Mol. Med. 82, 735-749. doi: 10.1007/s00109-004-0566-8.
80. Marin, Y. E., Namkoong, J., Cohen-Solal, K., Shin, S. S., Martino, J. J., Oka, M., et al. (2006). Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell. Signal. 18, 1279-1286. doi: 10.1016/j.cellsig.2005.10.012.
81. McCullough, J., Colf, L. A., and Sundquist, W. I. (2013). Membrane fission reactions of the mammalian ESCRT pathway. Annu. Rev. Biochem. 82, 663-692. doi: 10.1146/annurev-biochem-072909-101058.
82. Mehlen, P., and Puisieux, A. (2006). Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449-458. doi: 10.1038/nrc1886.
83. Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., and Nagata, S. (2007). Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435-439. doi: 10.1038/nature06307.
84. Myers, T. J., Brennaman, L. H., Stevenson, M., Higashiyama, S., Russell, W. E., Lee, D. C., et al. (2009). Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-alpha shedding. Mol. Biol. Cell 20, 5236-5249. doi: 10.1091/mbc. E08-12-1256.
85. Nakanishi, S. (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603. doi: 10.1126/science.1329206.
86. Namkoong, J., Shin, S. S., Lee, H. J., Marin, Y. E., Wall, B. A., Goydos, J. S., et al. (2007). Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res. 67, 2298-2305. doi: 10.1158/0008-5472.CAN-06-3665.
87. Newton, A. C. (2001). Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101, 2353-2364. doi: 10.1021/cr0002801.
88. O'Connell, J. T., Sugimoto, H., Cooke, V. G., MacDonald, B. A., Mehta, A. I., LeBleu, V. S., et al. (2011). VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc. Natl. Acad. Sci. U.S.A. 108, 16002-16007. doi: 10.1073/pnas.1109493108.
89. Odorizzi, G., Babst, M., and Emr, S. D. (1998). Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95, 847-858. doi: 10.1016/S0092-8674(00)81707-9.
90. Ohtani, Y., Harada, T., Funasaka, Y., Nakao, K., Takahara, C., Abdel-Daim, M., et al. (2008). Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma. Oncogene 27, 7162-7170. doi: 10.1038/onc.2008.329.
91. Ostrowski, M., Carmo, N. B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12, 19-30; sup pp 11-13. doi: 10.1038/ncb2000.
92. Pant, S., Hilton, H., and Burczynski, M. E. (2012). The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem. Pharmacol. 83, 1484-1494. doi: 10.1016/j.bcp.2011.12.037.
93. Park, S. Y., Lee, S. A., Han, I. H., Yoo, B. C., Lee, S. H., Park, J. Y., et al. (2007). Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol. Rep. 17, 81-87. doi: 10.3892/or.17.1.81.
94. Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., et al. (2009). Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284, 34211-34222. doi: 10.1074/jbc. M109.041152.
95. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812. doi: 10.1126/science.1164382.
96. Pauli, B. U., Schwartz, D. E., Thonar, E. J., and Kuettner, K. E. (1983). Tumor invasion and host extracellular matrix. Cancer Metastasis Rev. 2, 129-152. doi: 10.1007/BF00048966.
97. Peel, S., Macheboeuf, P., Martinelli, N., and Weissenhorn, W. (2011). Divergent pathways lead to ESCRT-III-catalyzed membrane fission. Trends Biochem. Sci. 36, 199-210. doi: 10.1016/j.tibs.2010.09.004.
98. Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891. doi: 10.1038/nm.2753.
99. Peter, B. J., Kent, H. M., Mills, I. G., Vallis, Y., Butler, P. J., Evans, P. R., et al. (2004). BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science 303, 495-499. doi: 10.1126/science.1092586.
100. Peters, P. J., Borst, J., Oorschot, V., Fukuda, M., Krahenbuhl, O., Tschopp, J., et al. (1991). Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173, 1099-1109. doi: 10.1084/jem.173.5.1099.
101. Pironti, G., Strachan, R. T., Abraham, D., Mon-Wei Yu, S., Chen, M., Chen, W., et al. (2015). Circulating exosomes induced by cardiac pressure overload contain functional angiotensin II type 1 receptors. Circulation 131, 2120-2130. doi: 10.1161/CIRCULATIONAHA.115.015687.
102. Pisitkun, T., Shen, R. F., and Knepper, M. A. (2004). Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U.S.A. 101, 13368-13373. doi: 10.1073/pnas.0403453101.
103. Pissimissis, N., Papageorgiou, E., Lembessis, P., Armakolas, A., and Koutsilieris, M. (2009). The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells. Anticancer Res. 29, 371-377.
104. Pollock, P. M., Cohen-Solal, K., Sood, R., Namkoong, J., Martino, J. J., Koganti, A., et al. (2003). Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat. Genet. 34, 108-112. doi: 10.1038/ng1148.
105. Poste, G., and Fidler, I. J. (1980). The pathogenesis of cancer metastasis. Nature 283, 139-146. doi: 10.1038/283139a0.
106. Prickett, T. D., and Samuels, Y. (2012). Molecular pathways: dysregulated glutamatergic signaling pathways in cancer. Clin. Cancer Res. 18, 4240-4246. doi: 10.1158/1078-0432.CCR-11-1217.
107. Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., et al. (1996). B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172. doi: 10.1084/jem.183.3.1161.
108. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., and Ratajczak, M. Z. (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495. doi: 10.1038/sj.leu.2404296.
109. Saari, H., Lazaro-Ibanez, E., Viitala, T., Vuorimaa-Laukkanen, E., Siljander, P., and Yliperttula, M. (2015). Microvesicle-and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J. Control. Release. 220(Pt B): 727-737. doi: 10.1016/j.jconrel.2015.09.031.
110. Savina, A., Furlan, M., Vidal, M., and Colombo, M. I. (2003). Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J. Biol. Chem. 278, 20083-20090. doi: 10.1074/jbc. M301642200.
111. Segura, E., Amigorena, S., and Thery, C. (2005). Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol. Dis. 35, 89-93. doi: 10.1016/j.bcmd.2005.05.003.
112. Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., et al. (2012). The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395-399. doi: 10.1038/nature10933.
113. Shin, S. S., Namkoong, J., Wall, B. A., Gleason, R., Lee, H. J., and Chen, S. (2008). Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res. 21, 368-378. doi: 10.1111/j.1755-148X.2008.00452.x.
114. Sjoblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274. doi: 10.1126/science.1133427.
115. Speyer, C. L., Smith, J. S., Banda, M., DeVries, J. A., Mekani, T., and Gorski, D. H. (2012). Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res. Treat. 132, 565-573. doi: 10.1007/s10549-011-1624-x.
116. Spiegel, A. M. (1996a). Defects in G protein-coupled signal transduction in human disease. Annu. Rev. Physiol. 58, 143-170. doi: 10.1146/annurev.ph.58.030196.001043.
117. Spiegel, A. M. (1996b). Mutations in G proteins and G protein-coupled receptors in endocrine disease. J. Clin. Endocrinol. Metab. 81, 2434-2442. doi: 10.1210/jcem.81.7.8675557.
118. Stepulak, A., Luksch, H., Gebhardt, C., Uckermann, O., Marzahn, J., Sifringer, M., et al. (2009). Expression of glutamate receptor subunits in human cancers. Histochem. Cell Biol. 132, 435-445. doi: 10.1007/s00418-009-0613-1.
119. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J., and Raposo, G. (2002). The biogenesis and functions of exosomes. Traffic 3, 321-330. doi: 10.1034/j.1600-0854.2002.30502.x.
120. Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., et al. (2011). The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160. doi: 10.1126/science.1208130.
121. Subra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau, G., Paillasse, M., et al. (2010). Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J. Lipid Res. 51, 2105-2120. doi: 10.1194/jlr. M003657.
122. Takei, K., Slepnev, V. I., Haucke, V., and De Camilli, P. (1999). Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis. Nat. Cell Biol. 1, 33-39. doi: 10.1038/9004.
123. Taylor, D. D., and Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21. doi: 10.1016/j.ygyno.2008.04.033.
124. Teh, J. L., and Chen, S. (2012). Glutamatergic signaling in cellular transformation. Pigment Cell Melanoma Res. 25, 331-342. doi: 10.1111/j.1755-148X.2012.00983.x.
125. Teh, J. L., Shah, R., La Cava, S., Dolfi, S. C., Mehta, M. S., Kongara, S., et al. (2015). Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells. Breast Cancer Res. Treat. 151, 57-73. doi: 10.1007/s10549-015-3365-8.
126. Thery, C. (2015). Cancer: diagnosis by extracellular vesicles. Nature 523, 161-162. doi: 10.1038/nature14626.
127. Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., et al. (2001). Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166, 7309-7318. doi: 10.4049/jimmunol.166.12.7309.
128. Thery, C., Regnault, A., Garin, J., Wolfers, J., Zitvogel, L., Ricciardi-Castagnoli, P., et al. (1999). Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147, 599-610. doi: 10.1083/jcb.147.3.599.
129. Thery, C., Zitvogel, L., and Amigorena, S. (2002). Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579. doi: 10.1038/nri855.
130. Thompson, C. A., Purushothaman, A., Ramani, V. C., Vlodavsky, I., and Sanderson, R. D. (2013). Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J. Biol. Chem. 288, 10093-10099. doi: 10.1074/jbc. C112.444562.
131. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., et al. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247. doi: 10.1126/science.1153124.
132. Tse, J. C., and Kalluri, R. (2007). Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem. 101, 816-829. doi: 10.1002/jcb.21215.
133. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596.
134. Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G., and Rivoltini, L. (2007). Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 67, 2912-2915. doi: 10.1158/0008-5472.CAN-07-0520.
135. van Niel, G., Raposo, G., Candalh, C., Boussac, M., Hershberg, R., Cerf-Bensussan, N., et al. (2001). Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121, 337-349. doi: 10.1053/gast.2001.26263.
136. Van Raamsdonk, C. D., Fitch, K. R., Fuchs, H., de Angelis, M. H., and Barsh, G. S. (2004). Effects of G-protein mutations on skin color. Nat. Genet. 36, 961-968. doi: 10.1038/ng1412.
137. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., et al. (2001). The sequence of the human genome. Science 291, 1304-1351. doi: 10.1126/science.1058040.
138. Viaud, S., Thery, C., Ploix, S., Tursz, T., Lapierre, V., Lantz, O., et al. (2010). Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res. 70, 1281-1285. doi: 10.1158/0008-5472.CAN-09-3276.
139. Wang, Q., Navarro, M. V., Peng, G., Molinelli, E., Goh, S. L., Judson, B. L., et al. (2009). Molecular mechanism of membrane constriction and tubulation mediated by the F-BAR protein Pacsin/Syndapin. Proc. Natl. Acad. Sci. U.S.A. 106, 12700-12705. doi: 10.1073/pnas.0902974106.
140. Wang, Z., and Ouyang, G. (2012). Periostin: a bridge between cancer stem cells and their metastatic niche. Cell Stem Cell 10, 111-112. doi: 10.1016/j.stem.2012.01.002.
141. Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjoblom, T., Leary, R. J., et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113. doi: 10.1126/science.1145720.
142. Wu, H., Wang, C., Gregory, K. J., Han, G. W., Cho, H. P., Xia, Y., et al. (2014). Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator. Science 344, 58-64. doi: 10.1126/science.1249489.
143. Yakubenko, V. P., Lobb, R. R., Plow, E. F., and Ugarova, T. P. (2000). Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp. Cell Res. 260, 73-84. doi: 10.1006/excr.2000.5002.
144. Young, D., Waitches, G., Birchmeier, C., Fasano, O., and Wigler, M. (1986). Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45, 711-719. doi: 10.1016/0092-8674(86)90785-3.
145. Yu, X., Harris, S. L., and Levine, A. J. (2006). The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 66, 4795-4801. doi: 10.1158/0008-5472.CAN-05-4579.
146. Zhao, H., Yang, L., Baddour, J., Achreja, A., Bernard, V., Moss, T., et al. (2016). Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife 5:e10250. doi: 10.7554/eLife.10250. [Epub ahead of print].
147. Zhu, H., Reuhl, K., Zhang, X., Botha, R., Ryan, K., Wei, J., et al. (1998). Development of heritable melanoma in transgenic mice. J. Invest. Dermatol. 110, 247-252. doi: 10.1046/j.1523-1747.1998.00133.x.